Biomatter

We build impossible enzymes for your visionary products.

Vilnius · Founded 2018 · $6.5M raised

Headquarters
Vilnius
Founded
2018
Business Model
B2B
Total Funding
$6.5M
Last Round
$6.5M SeedAug 2024
Rounds
1

About

Biomatter is a synthetic biology company based in Vilnius, Lithuania, that builds exceptional enzymes for health and sustainable manufacturing applications. Its proprietary Intelligent Architecture™ platform enables near-perfect control over protein design, allowing creation of previously impossible enzymes and enzyme-based products. Biomatter partners with leading global companies on projects ranging from stand-alone enzyme products to multi-enzyme chemical manufacturing solutions, supporting clients from initial concept and design through experimental validation, scale-up, and protein production.

Summary

Biomatter is a Biotech company based in Vilnius, founded in 2018. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Aug 2024.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedAug 2024
$6.5M

Similar Companies